In July, Solve hosted a webinar featuring representatives of the ADDRESS-LC Trial, which was designed to assess the potential impact of the drug bezisterim on cognitive impairment/brain fog and fatigue […] The post Patient Feedback Spurs Expansion of ADDRESS-LC Trial: More Test Sites, Broader Enrollment appeared first on Solve ME/CFS Initiative.
